Analyst Research

Report Title Price
Thomson Reuters Stock Report - ENDO PHARMACEUTICALS HOLDINGS INCORPORATION (ENDP-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
ValuEngine Detailed Valuation Report for ENDP
Provider: ValuEngine, Inc.
$127.00
Buy
Endo Health Solutions Inc. (ENDP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy
Market Edge Equity Research Report
Provider: Market Edge
$10.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Endo Health Solutions Inc Announces Authorization Of $450 Million Share Repurchase Program


Tuesday, 7 Aug 2012 06:55am EDT 

Endo Health Solutions Inc announced that its Board of Directors has authorized the Company to repurchase up to $450 million of its common stock through March 2015. The repurchases will be made using cash resources, and the program may be suspended or discontinued at any time with prior notice. 

Latest Developments for Endo Health Solutions Inc

Latest Key Developments in Pharmaceuticals

Company Quote

Endo Health Solutions Inc
(ENDP.O)
34.28
0.66 +1.96%
23 May 2013